Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23125591 | 0.94 | RXFP1 (0.35) | LMNAMAPTRXFP1POLBALDH1A1 | |
| SCHEMBL23125638 | 0.85 | PGR (0.33) | LMNAMAPTRXFP1POLBALDH1A1 | |
| SCHEMBL23125658 | 0.82 | MEN1 (0.37) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL13143183 | 0.81 | RXFP1 (0.41) | MEN1KMT2ALMNAMAPTRXFP1 | |
| SCHEMBL20383375 | 0.81 | MEN1 (0.47) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22639658 | 0.81 | MEN1 (0.35) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22639655 | 0.81 | MEN1 (0.35) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL23125664 | 0.79 | HTT (0.35) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22639822 | 0.79 | PGR (0.39) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL23125644 | 0.79 | TP53 (0.34) | LMNAMAPTOPRK1SMN1; SMN2RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10954254-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10954254-B2 | Heterocyclic compound and organic light-emitting device including the same | TYR, DDT, LEF1 | MEN1 857/4885KMT2A 1282/4885KDM4E 1476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.